Algorae Pharmaceuticals Limited
LVCLF
$0.0063
$0.000916.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -212.70K | -218.70K | -212.30K | -211.90K | -472.80K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.60K | -16.00K | 113.50K | 113.30K | 144.20K |
| Change in Net Operating Assets | -- | -- | -70.80K | -70.60K | -- |
| Cash from Operations | -228.30K | -234.70K | -169.60K | -169.20K | -328.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 65.20K | 67.00K | 230.60K | 230.20K | -318.50K |
| Cash from Investing | 65.20K | 67.00K | 230.60K | 230.20K | -318.50K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 25.80K | 25.80K | 260.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -24.60K | -24.60K | -- |
| Cash from Financing | -- | -- | 800.00 | 800.00 | 169.70K |
| Foreign Exchange rate Adjustments | -300.00 | -300.00 | -500.00 | -500.00 | -200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -163.40K | -168.00K | 61.30K | 61.10K | -477.70K |